196 related articles for article (PubMed ID: 8761892)
1. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport.
Muriana FJ; Villar J; Ruíz-Gutiérrez V
J Hypertens; 1996 Apr; 14(4):443-6. PubMed ID: 8761892
[TBL] [Abstract][Full Text] [Related]
2. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
Carr SJ; Sikand K; Moore D; Norman RI
J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte Na(+)-Li+ countertransport in essential hypertension: correlation with membrane lipids levels.
Villar J; Montilla C; Muñiz-Grijalvo O; Muriana FG; Stiefel P; Ruiz-Gutiérrez V; Carneado J
J Hypertens; 1996 Aug; 14(8):969-73. PubMed ID: 8884551
[TBL] [Abstract][Full Text] [Related]
4. Distribution of erythrocyte membrane cholesterol in human essential hypertension.
Muriana FJ; García-Donas MA; Villar J; Ruíz-Gutiérrez V
J Hypertens; 1994 Dec; 12(12):1383-6. PubMed ID: 7706698
[TBL] [Abstract][Full Text] [Related]
5. The rate of transbilayer movement of erythrocyte membrane cholesterol is correlated with sodium-lithium countertransport.
Muriana FJ; Montilla C; Stiefel P; Villar J; Ruíz-Gutiérrez V
Life Sci; 1996; 59(23):1945-9. PubMed ID: 8950293
[TBL] [Abstract][Full Text] [Related]
6. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
7. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension.
Weder AB
N Engl J Med; 1986 Jan; 314(4):198-201. PubMed ID: 3941708
[TBL] [Abstract][Full Text] [Related]
8. Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.
Savopoulos CG; Hatzitolios AI; Katsiki NA; Baltatzi M; Kosmidou M; Raikos N; Mikhailidis DP; Ziakas AG; Kaiafa G; Tsesmeli N
Angiology; 2008 Dec-2009 Jan; 59(6):727-35. PubMed ID: 18840623
[TBL] [Abstract][Full Text] [Related]
9. Increased sodium-lithium countertransport in red cells of patients with essential hypertension.
Canessa M; Adragna N; Solomon HS; Connolly TM; Tosteson DC
N Engl J Med; 1980 Apr; 302(14):772-6. PubMed ID: 7354809
[TBL] [Abstract][Full Text] [Related]
10. Sodium, lithium-countertransport and blood pressure control by nutritional intervention in 'mild' hypertension.
McDonald AM; Dyer AR; Liu K; Stamler R; Gosch FC; Grimm R; Berman R; Stamler J
J Hypertens; 1988 Apr; 6(4):283-91. PubMed ID: 2454254
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds.
Dadone MM; Hasstedt SJ; Hunt SC; Smith JB; Ash KO; Williams RR
Am J Med Genet; 1984 Mar; 17(3):565-77. PubMed ID: 6585142
[TBL] [Abstract][Full Text] [Related]
12. Sodium-lithium countertransport and the Gly460-->Trp alpha-adducin polymorphism in essential hypertension.
Mead PA; Harvey JN; Rutherford PA; Leitch H; Thomas TH
Clin Sci (Lond); 2005 Mar; 108(3):231-6. PubMed ID: 15554870
[TBL] [Abstract][Full Text] [Related]
13. Relation of sodium-lithium countertransport activity to markers of cardiovascular risk in normotensive subjects.
Hardman TC; Dubrey SW; Soni S; Lant AF
J Hum Hypertens; 1995 Jul; 9(7):589-96. PubMed ID: 7562890
[TBL] [Abstract][Full Text] [Related]
14. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
Caballero Oliver A; Stiefel García-Junco P; García-Donas López MA; Villar Ortiz J; Carneado de la Fuente J
Med Clin (Barc); 1995 Dec; 105(20):768-73. PubMed ID: 8558976
[TBL] [Abstract][Full Text] [Related]
15. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy.
Jensen JS; Mathiesen ER; Nørgaard K; Hommel E; Borch-Johnsen K; Funder J; Brahm J; Parving HH; Deckert T
Diabetologia; 1990 Oct; 33(10):619-24. PubMed ID: 2257999
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension.
Stiefel P; Montilla C; Muñiz-Grijalvo O; García-Lozano R; Alonso A; Miranda ML; Pamies E; Villar J
Metabolism; 2001 Feb; 50(2):157-60. PubMed ID: 11229422
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.
Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG
Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253
[TBL] [Abstract][Full Text] [Related]
18. Transbilayer movement of erythrocyte membrane cholesterol in human essential hypertension.
Muriana FJ; Montilla C; Villar J; Ruíz-Gutiérrez V
J Hypertens; 1995 Jun; 13(6):619-23. PubMed ID: 7594418
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of sodium-lithium countertransport in red cells.
Woods JW; Parker JC; Watson BS
N Engl J Med; 1983 May; 308(21):1258-61. PubMed ID: 6843610
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological studies of sodium transport and hypertension.
McDonald A; Trevisan M; Cooper R; Stamler R; Gosch F; Ostrow D; Stamler J
Hypertension; 1987 Nov; 10(5 Pt 2):I42-7. PubMed ID: 2824365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
